Thursday December 5, 2019

Dublin Medtech start-up wins €2.7m in funding

Oncomark’s diagnostic tech helps breast cancer patients avoid unnecessary chemotherapy

13th September, 2015
Mairin Rafferty, chief operations officer of Oncomark, with chief executive Desmond O'Leary and chief science officer William Gallagher

Done deal:€2.7m funding

The clincher: “This award will enable us to accelerate the OncoMasTR test from the laboratory to the clinic, as well as creating employment opportunities.” - Des O’Leary, chief executive, OncoMark

Diagnostic technology that could help breast cancer patients avoid unnecessary post-operative chemotherapy has earned a Dublin start-up €2.7 million in funding.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Mortgage gouging by banks does not serve society well

Matt Cooper | 2 weeks ago